Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial.

doi:10.1002/alz.71796

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Sept 2026

Ottman Ruth, Wetmore John B, Leu Cheng-Shiun, Uhlmann Wendy R, Goldman Jill, Rodriguez Sophia, Diaz Caro Daniela, Cabán María, McCain Sarah, Blasco Drew, Lantigua Rafael A, Abraido-Lanza Ana, Chung Wendy K, Roberts J Scott, Siegel Karolynn

Abstract excerpt

INTRODUCTION: Latinos face increased Alzheimer's disease (AD) risk but are underrepresented in studies of APOE genotype disclosure. We evaluated the psychological impacts of APOE disclosure in the Información de la Enfermedad de Alzheimer para Latinos (IDEAL) study, a randomized controlled trial among Latinos in New York City. METHODS: Latino northern Manhattan residents without self-reported AD (mean age 52, 69%...

Read the complete abstract on PubMed

Topics

Aged
Aged, 80 and over
Female
Humans
Male

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Middle Aged

Alzheimer Disease

Apolipoproteins E

Disclosure

Genetic Testing

Genotype

Hispanic or Latino

New York City

Source

Open in PubMed Open full text

Identifiers

PMID: 42712082
DOI: 10.1002/alz.71796
PMCID: PMC13554978

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial.PMID 42712082Read ↗

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino populationSemantic proximity Read ↗

Exploring immediate responses to APOEε4/ε4 genotype and Alzheimer's disease risk disclosure in Latinos.Semantic proximity Read ↗

Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress.Semantic proximity Read ↗

Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.Semantic proximity Read ↗

Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.Semantic proximity Read ↗

Disclosure of APOE genotype for risk of Alzheimer's disease.Semantic proximity Read ↗

Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1.Semantic proximity Read ↗

A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.Semantic proximity Read ↗

The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry.Semantic proximity Read ↗

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Semantic proximity Read ↗

APOE Genotype Disclosure Influences Decisions About Future Planning but not Adoption of Healthy Lifestyle Changes in Cognitively Unimpaired Individuals.Semantic proximity Read ↗

Recommendations for genetic counseling for individuals at risk of autosomal dominant Alzheimer's disease in Latin America.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.